Coralia Bleotu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Coralia Bleotu has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Mariana Carmen Chifiriuc
Department of Botany and Microbiology, Faculty of Biology, University of Bucharest, 030018 Bucharest, Romania
102 shared publications - Carmen Cristina Diaconu
Department of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Romanian Academy, 030304 Bucharest, Romania
45 shared publications - Lilia Matei
Stefan S. Nicolau Institute of Virology, 030304 Bucharest, Romania
28 shared publications - Mihaela Chivu-Economescu
Stefan S. Nicolau Institute of Virology, Romanian Academy, 030304 Bucharest, Romania
25 shared publications - Luminita Marutescu
Department of Botany and Microbiology, Faculty of Biology, University of Bucharest, Bucharest, Romania
23 shared publications - Alexandru Mihai Grumezescu
Department of Science and Engineering of Oxide Materials and Nanomaterials, Faculty of Chemical Engineering and Biotechnologies, National University of Science and Technology POLITEHNICA Bucharest, 1-7 Gheorghe Polizu Street, 011061 Bucharest, Romania
21 shared publications
Latest Publications
- Open Access
- 1 August 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (8) , 1741
Differential Expression and Co-Variation of HERV-Associated Transcripts, IL-17 Cytokines, and NFκB in Paired Colorectal Cancer Tissues
Background: The mechanistic link between HERV-associated transcript expression and the inflammatory pathways involved in colorectal cancer (CRC), particularly the IL-17 axis, remains insufficiently characterized. We performed an exploratory paired-tissue study to investigate whether HERV-associated transcript deregulation in CRC aligns with a distinct local inflammatory signature, potentially consistent with endogenous retroviral re-expression linked to local immune activation and viral mimicry-related processes within the tumor microenvironment. Methods: Matched colorectal tumor tissue (T) and histologically tumor-free adjacent tissue (N) were obtained from 21 treatment-naive CRC patients. Expression of selected HERV-associated loci/transcripts (HERV-FRD, HERV-R, HERV-K, HERV-V1, HERV-1, HERV-H, and ERVWE1), HHLA1/HHLA2, IL-17 family members, and NFKB1 was assessed by RT–qPCR. Results: CRC tumors exhibited selective upregulation of HERV-FRD, HERV-R, HERV-K, HERV-V1, ERVWE1, HHLA1, and HHLA2, whereas HERV-1 and HERV-H showed no significant paired differences. IL-17E was also increased in tumor tissue, while NFKB1 did not show significant paired variation. Paired differential expression analysis [Δ(T−N)] identified a coordinated HERV/ERVWE1 signature that positively correlated with IL-17E after FDR correction, whereas HHLA1/HHLA2 displayed partially distinct behavior. No consistent associations were observed with clinicopathological variables. Conclusions: CRC appears to harbor a selective HERV/ERVWE1-associated transcriptional program linked to IL-17E, supporting a candidate inflammatory axis that may reflect a biologically relevant component of the tumor microenvironment. This expression pattern may also be compatible with a localized endogenous retroviral reactivation state linked to viral mimicry-related inflammatory signaling, although this interpretation remains indirect and requires mechanistic validation. These findings are associative and hypothesis-generating, but they provide a conceptual basis for future mechanistic validation and for exploring whether HERV-linked inflammatory signatures may have biomarker or therapeutic relevance in CRC.
- 1 August 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (8) , 1741
Open AccessDifferential Expression and Co-Variation of HERV-Associated Transcripts, IL-17 Cytokines, and NFκB in Paired Colorectal Cancer Tissues
Background: The mechanistic link between HERV-associated transcript expression and the inflammatory pathways involved in colorectal cancer (CRC), particularly the IL-17 axis, remains insufficiently characterized. We performed an exploratory paired-tissue study to investigate whether HERV-associated transcript deregulation in CRC aligns with a distinct local inflammatory signature, potentially consistent with endogenous retroviral re-expression linked to local immune activation and viral mimicry-related processes within the tumor microenvironment. Methods: Matched colorectal tumor tissue (T) and histologically tumor-free adjacent tissue (N) were obtained from 21 treatment-naive CRC patients. Expression of selected HERV-associated loci/transcripts (HERV-FRD, HERV-R, HERV-K, HERV-V1, HERV-1, HERV-H, and ERVWE1), HHLA1/HHLA2, IL-17 family members, and NFKB1 was assessed by RT–qPCR. Results: CRC tumors exhibited selective upregulation of HERV-FRD, HERV-R, HERV-K, HERV-V1, ERVWE1, HHLA1, and HHLA2, whereas HERV-1 and HERV-H showed no significant paired differences. IL-17E was also increased in tumor tissue, while NFKB1 did not show significant paired variation. Paired differential expression analysis [Δ(T−N)] identified a coordinated HERV/ERVWE1 signature that positively correlated with IL-17E after FDR correction, whereas HHLA1/HHLA2 displayed partially distinct behavior. No consistent associations were observed with clinicopathological variables. Conclusions: CRC appears to harbor a selective HERV/ERVWE1-associated transcriptional program linked to IL-17E, supporting a candidate inflammatory axis that may reflect a biologically relevant component of the tumor microenvironment. This expression pattern may also be compatible with a localized endogenous retroviral reactivation state linked to viral mimicry-related inflammatory signaling, although this interpretation remains indirect and requires mechanistic validation. These findings are associative and hypothesis-generating, but they provide a conceptual basis for future mechanistic validation and for exploring whether HERV-linked inflammatory signatures may have biomarker or therapeutic relevance in CRC.
- Open Access
- 19 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (10) , 4557
Critical Role of Molecular-Based Stratification in Low-Risk Myelodysplastic Syndrome with Direct Progression to Acute Myeloid Leukemia: A Case Report
The genomic landscape of myelodysplastic syndromes/neoplasms (MDS), a heterogeneous group of myeloid malignancies defined by bone marrow cell dysplasia with ineffective hematopoiesis, includes somatic and, less frequently, germline mutations in hematopoietic stem and progenitor cells, along with chromosomal abnormalities. The latest World Health Organization 2022 classification of myeloid neoplasms, as well as stratification in lower-risk (LR) and higher-risk (HR) MDS using either the Revised International Prognostic Scoring System (IPSS-R) or the Molecular International Prognostic Scoring System (IPSS-M), guide prognostic assessment and risk-adjusted therapy. We report the case of an 81-year-old patient diagnosed with LR-MDS according to IPSS-R that exhibited direct progression to acute myeloid leukemia. The retrospective analysis of paired DNA samples from MDS and leukemic phases, obtained four months apart, using both targeted next-generation sequencing and single nucleotide polymorphism array, indicated swift alterations in the genomic profile, being suggested that the leukemic clone emerged from the clone harboring homozygous TET2 and heterozygous SRSF2 variants that acquired RUNX1, BCOR, BCORL1 likely pathogenic mutations and trisomy 13. By employing IPSS-M for prognostic evaluation at the MDS phase, the patient would have been assigned to the HR-MDS category with a possible benefit from hypomethylating agent therapy. Risk stratification is of pivotal importance in a patient-centered approach to MDS treatment being significantly improved by incorporating the molecular genetic findings.
- 19 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (10) , 4557
Open AccessCritical Role of Molecular-Based Stratification in Low-Risk Myelodysplastic Syndrome with Direct Progression to Acute Myeloid Leukemia: A Case Report
The genomic landscape of myelodysplastic syndromes/neoplasms (MDS), a heterogeneous group of myeloid malignancies defined by bone marrow cell dysplasia with ineffective hematopoiesis, includes somatic and, less frequently, germline mutations in hematopoietic stem and progenitor cells, along with chromosomal abnormalities. The latest World Health Organization 2022 classification of myeloid neoplasms, as well as stratification in lower-risk (LR) and higher-risk (HR) MDS using either the Revised International Prognostic Scoring System (IPSS-R) or the Molecular International Prognostic Scoring System (IPSS-M), guide prognostic assessment and risk-adjusted therapy. We report the case of an 81-year-old patient diagnosed with LR-MDS according to IPSS-R that exhibited direct progression to acute myeloid leukemia. The retrospective analysis of paired DNA samples from MDS and leukemic phases, obtained four months apart, using both targeted next-generation sequencing and single nucleotide polymorphism array, indicated swift alterations in the genomic profile, being suggested that the leukemic clone emerged from the clone harboring homozygous TET2 and heterozygous SRSF2 variants that acquired RUNX1, BCOR, BCORL1 likely pathogenic mutations and trisomy 13. By employing IPSS-M for prognostic evaluation at the MDS phase, the patient would have been assigned to the HR-MDS category with a possible benefit from hypomethylating agent therapy. Risk stratification is of pivotal importance in a patient-centered approach to MDS treatment being significantly improved by incorporating the molecular genetic findings.
- Open Access
- 7 May 2026
- Published by MDPI AG in Biomimetics
- Vol. 11 (5) , 327
Physico-Chemical and Biological Evaluation of Spin-Coated Chromium-Doped Hydroxyapatite in Dextran Matrix Coatings
This study reports on the physico-chemical and in vitro biological characterization of chromium-doped hydroxyapatite (10CrHAp, Cr3+, Ca10-xCrx(PO4)6(OH)2, xCr = 0.1) and chromium-doped hydroxyapatite in dextran matrix (10CrHAp-Dx) coatings, prepared for the first time via the spin coating technique. X-ray diffraction analysis and Rietveld refinement were used to characterize the materials. Fourier-transform infrared (FTIR) spectroscopy confirmed the presence of functional groups specific to hydroxyapatite. Scanning electron microscopy (SEM) observations revealed the presence of a conglomerate of nanoparticles distributed unevenly across the coatings surface. Atomic force microscopy (AFM) showed that both coatings presented continuous surfaces with uniform morphology. The in vitro biocompatibility of 10CrHAp and 10CrHAp-Dx coatings was evaluated using human osteoblast-like MG63 cell line and MTT assay. SEM and MM visualization assessed the cell adhesion and proliferation and morphological changes in the adhered cells. The antibacterial properties of the 10CrHAp and 10CrHAp-Dx coatings was assessed in vitro against two of the most common bacterial reference strains, Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATCC 25923. Overall, the coatings achieved log reductions up to ~9.35, corresponding to a bacterial kill rate (for S. aureus) exceeding 99.99%, with 10CrHAp-Dx showing slightly superior performance. Similar behavior (log reductions of ~8.6 and ~8.9, respectively, indicating a sustained antibacterial effect and >99.99% bacterial elimination) was observed and for Pseudomonas aeruginosa. AFM was used to evaluate the bacterial cells interaction with the coating’s surfaces. The biological assays demonstrated that both coatings possess notable antibacterial activity, underscoring their potential in biomedical applications, particularly in the design of new antimicrobial devices.
- 7 May 2026
- Published by MDPI AG in Biomimetics
- Vol. 11 (5) , 327
Open AccessPhysico-Chemical and Biological Evaluation of Spin-Coated Chromium-Doped Hydroxyapatite in Dextran Matrix Coatings
This study reports on the physico-chemical and in vitro biological characterization of chromium-doped hydroxyapatite (10CrHAp, Cr3+, Ca10-xCrx(PO4)6(OH)2, xCr = 0.1) and chromium-doped hydroxyapatite in dextran matrix (10CrHAp-Dx) coatings, prepared for the first time via the spin coating technique. X-ray diffraction analysis and Rietveld refinement were used to characterize the materials. Fourier-transform infrared (FTIR) spectroscopy confirmed the presence of functional groups specific to hydroxyapatite. Scanning electron microscopy (SEM) observations revealed the presence of a conglomerate of nanoparticles distributed unevenly across the coatings surface. Atomic force microscopy (AFM) showed that both coatings presented continuous surfaces with uniform morphology. The in vitro biocompatibility of 10CrHAp and 10CrHAp-Dx coatings was evaluated using human osteoblast-like MG63 cell line and MTT assay. SEM and MM visualization assessed the cell adhesion and proliferation and morphological changes in the adhered cells. The antibacterial properties of the 10CrHAp and 10CrHAp-Dx coatings was assessed in vitro against two of the most common bacterial reference strains, Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATCC 25923. Overall, the coatings achieved log reductions up to ~9.35, corresponding to a bacterial kill rate (for S. aureus) exceeding 99.99%, with 10CrHAp-Dx showing slightly superior performance. Similar behavior (log reductions of ~8.6 and ~8.9, respectively, indicating a sustained antibacterial effect and >99.99% bacterial elimination) was observed and for Pseudomonas aeruginosa. AFM was used to evaluate the bacterial cells interaction with the coating’s surfaces. The biological assays demonstrated that both coatings possess notable antibacterial activity, underscoring their potential in biomedical applications, particularly in the design of new antimicrobial devices.
- Open Access
- 13 March 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (3) , 426
Differential Plasma Expression of sTNF-R, TNF-α, PDGF-AA, IL-17A, and IL-1β Across the Colorectal Neoplasia Spectrum
Colorectal cancer (CRC) remains one of the most important causes of cancer-related mortality worldwide, underscoring the need to better understand systemic inflammatory pathways across the colorectal neoplasia spectrum. In this exploratory case–control study, we characterized plasma levels of key inflammatory mediators in healthy individuals and patients with colorectal polyps or CRC. Healthy controls (n = 10), patients with colorectal polyps (CP, n = 16), early-onset CRC (EO-CRC, n = 11), and late-onset CRC (LO-CRC, n = 51) were prospectively enrolled. Plasma levels of sTNF-R, total TNF-α, PDGF-AA, IL-17A, and IL-1β were measured by ELISA. Group comparisons used Kruskal–Wallis tests with epsilon-squared effect sizes. PDGF-AA showed the strongest differences between controls and all neoplastic groups (ε2 ≥ 0.15), and these comparisons remained significant after Benjamini–Hochberg false discovery rate correction. IL-17A levels were slightly higher in EO-CRC than in LO-CRC; however, this difference did not remain significant after adjustment for multiple testing. TNF-α and IL-1β showed no significant differences across groups. Overall, this study primarily provides descriptive and hypothesis-generating evidence of differential inflammatory patterns across colorectal neoplasia, with PDGF-AA emerging as the most robust signal in this exploratory dataset. These findings do not support immediate diagnostic application and require validation in larger, prospectively recruited cohorts.
- 13 March 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (3) , 426
Open AccessDifferential Plasma Expression of sTNF-R, TNF-α, PDGF-AA, IL-17A, and IL-1β Across the Colorectal Neoplasia Spectrum
Colorectal cancer (CRC) remains one of the most important causes of cancer-related mortality worldwide, underscoring the need to better understand systemic inflammatory pathways across the colorectal neoplasia spectrum. In this exploratory case–control study, we characterized plasma levels of key inflammatory mediators in healthy individuals and patients with colorectal polyps or CRC. Healthy controls (n = 10), patients with colorectal polyps (CP, n = 16), early-onset CRC (EO-CRC, n = 11), and late-onset CRC (LO-CRC, n = 51) were prospectively enrolled. Plasma levels of sTNF-R, total TNF-α, PDGF-AA, IL-17A, and IL-1β were measured by ELISA. Group comparisons used Kruskal–Wallis tests with epsilon-squared effect sizes. PDGF-AA showed the strongest differences between controls and all neoplastic groups (ε2 ≥ 0.15), and these comparisons remained significant after Benjamini–Hochberg false discovery rate correction. IL-17A levels were slightly higher in EO-CRC than in LO-CRC; however, this difference did not remain significant after adjustment for multiple testing. TNF-α and IL-1β showed no significant differences across groups. Overall, this study primarily provides descriptive and hypothesis-generating evidence of differential inflammatory patterns across colorectal neoplasia, with PDGF-AA emerging as the most robust signal in this exploratory dataset. These findings do not support immediate diagnostic application and require validation in larger, prospectively recruited cohorts.
- Open Access
- 3 February 2026
- Published by MDPI AG in Preprints.org
Lactoferrin and Probiotic-Derived Supernatants as Adjuvants for Managing Multidrug-Resistant Opportunistic Infections
Multidrug resistance (MDR) is a major global health challenge, necessitating alternative or adjuvant strategies such as lactoferrin (Lf) and probiotics. Opportunistic bacteria are key drivers of healthcare-associated infections (HAIs) due to their ability to form biofilms and cause persistent infections. Lf, a glycoprotein present in mammalian milk and secretions, exhibits antimicrobial properties as part of innate immunity. Similarly, probiotics—primarily lactic acid bacteria (LAB)—influence pathogen growth and adhesion. This study evaluated the antimicrobial and anti-biofilm effects of purified bovine Lf (bLf) versus commercial Lf, alone and combined with LAB-derived supernatants, against several opportunistic strains. Using qualitative and quantitative methods, we assessed the antimicrobial, anti-adherence, and immunomodulatory activities of bLf (Sigma-Aldrich), commercial Lf (Jarrow Formulas), and LAB supernatants. High-purity bLf demonstrated superior antimicrobial and antibiofilm effects compared to supplement-derived Lf. Furthermore, commercial Lf, combined with LAB metabolites, effectively inhibited biofilm formation, reduced inflammation, and prevented bacterial adhesion to eukaryotic cells. These findings support the potential use of lactoferrin, alone or in synergy with probiotics, as adjuvants or prophylactic agents, particularly for immunocompromised patients, to limit bacterial adherence and prevent chronic infections.
- 3 February 2026
- Published by MDPI AG in Preprints.org
Open AccessLactoferrin and Probiotic-Derived Supernatants as Adjuvants for Managing Multidrug-Resistant Opportunistic Infections
Multidrug resistance (MDR) is a major global health challenge, necessitating alternative or adjuvant strategies such as lactoferrin (Lf) and probiotics. Opportunistic bacteria are key drivers of healthcare-associated infections (HAIs) due to their ability to form biofilms and cause persistent infections. Lf, a glycoprotein present in mammalian milk and secretions, exhibits antimicrobial properties as part of innate immunity. Similarly, probiotics—primarily lactic acid bacteria (LAB)—influence pathogen growth and adhesion. This study evaluated the antimicrobial and anti-biofilm effects of purified bovine Lf (bLf) versus commercial Lf, alone and combined with LAB-derived supernatants, against several opportunistic strains. Using qualitative and quantitative methods, we assessed the antimicrobial, anti-adherence, and immunomodulatory activities of bLf (Sigma-Aldrich), commercial Lf (Jarrow Formulas), and LAB supernatants. High-purity bLf demonstrated superior antimicrobial and antibiofilm effects compared to supplement-derived Lf. Furthermore, commercial Lf, combined with LAB metabolites, effectively inhibited biofilm formation, reduced inflammation, and prevented bacterial adhesion to eukaryotic cells. These findings support the potential use of lactoferrin, alone or in synergy with probiotics, as adjuvants or prophylactic agents, particularly for immunocompromised patients, to limit bacterial adherence and prevent chronic infections.
- Open Access
- 14 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 11043
COL10A1 Overexpression Promotes Gastric Cancer Aggressiveness Through EMT and Major Oncogenic Pathways
Gastric cancer (GC) remains a major cause of cancer-related mortality, with limited options for early detection and precision therapy. Collagen family members are increasingly recognized as key structural and regulatory components of the tumor microenvironment. Collagen type X alpha 1 chain (COL10A1) appears among the top overexpressed genes in GC and has been linked with tumorigenesis, but its functional role in GC has not been completely elucidated. The oncogenic potential of COL10A1 was assessed in vitro in GC cell lines using adenoviral-mediated overexpression. Functional assays were further performed to evaluate proliferation, apoptosis, migration, invasion, and epithelial–mesenchymal transition (EMT) markers. Intracellular signaling alterations were analyzed by phosphokinase protein profiling and protein–protein interaction network analysis. COL10A1 overexpression significantly increased proliferation and migration, while reducing GC cell apoptosis. It promotes EMT by up-regulating mesenchymal markers (N-cadherin, Vimentin, Snail/Slug) and suppressing epithelial markers such as E-cadherin and β-catenin. Additionally, COL10A1 overexpression activated oncogenic signaling pathways, including the JNK and MAPK cascades, increasing proliferation and tumorigenic potential. Our results showed that COL10A1 functions as a driver for tumor progression by promoting proliferation, migration, and invasion along with EMT through activation of important oncogenic pathways. These findings highlight its biological role in tumor progression and contribute to a better understanding of GC pathogenesis.
- 14 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 11043
Open AccessCOL10A1 Overexpression Promotes Gastric Cancer Aggressiveness Through EMT and Major Oncogenic Pathways
Gastric cancer (GC) remains a major cause of cancer-related mortality, with limited options for early detection and precision therapy. Collagen family members are increasingly recognized as key structural and regulatory components of the tumor microenvironment. Collagen type X alpha 1 chain (COL10A1) appears among the top overexpressed genes in GC and has been linked with tumorigenesis, but its functional role in GC has not been completely elucidated. The oncogenic potential of COL10A1 was assessed in vitro in GC cell lines using adenoviral-mediated overexpression. Functional assays were further performed to evaluate proliferation, apoptosis, migration, invasion, and epithelial–mesenchymal transition (EMT) markers. Intracellular signaling alterations were analyzed by phosphokinase protein profiling and protein–protein interaction network analysis. COL10A1 overexpression significantly increased proliferation and migration, while reducing GC cell apoptosis. It promotes EMT by up-regulating mesenchymal markers (N-cadherin, Vimentin, Snail/Slug) and suppressing epithelial markers such as E-cadherin and β-catenin. Additionally, COL10A1 overexpression activated oncogenic signaling pathways, including the JNK and MAPK cascades, increasing proliferation and tumorigenic potential. Our results showed that COL10A1 functions as a driver for tumor progression by promoting proliferation, migration, and invasion along with EMT through activation of important oncogenic pathways. These findings highlight its biological role in tumor progression and contribute to a better understanding of GC pathogenesis.
- Open Access
- 25 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7585
Serum Behavior of NT-3 and VEGFβ, Two Unstudied Growth Factors in Patients with Diabetes Mellitus and End-Stage Renal Disease
Background. DM frequently causes ESRD, a situation in which survival is impossible without chronic dialysis. This research aimed to study the tissue-regenerative capacity of ESRD patients with/without DM. For this purpose, two growth factors were studied: NT-3 and VEGFβ. To our knowledge, this is the first study on the serum behavior of NT-3 in patients with ESRD + DM and, very likely, in patients with ESRD alone. VEGFβ is also very little studied in these patient categories. Since the quasi-permanent inflammation was already clearly proven, this study focused on the anti-inflammatory capacity, taking IL-10 as a prototype, and also the interrelationships between these three factors. Method. All the aforementioned compounds were determined from serum samples, utilizing ELISA kits. Results. The results were surprising, proving a marked polarization of their serum behavior. Although the mean serum levels of NT-3 and VEGFβ were significantly increased in patients with ESRD + DM compared to those with ESRD alone, most patients in both groups had serum levels below the detection limits of the kits used. Conclusions. Although this research is in its early stages, it generates important conclusions and directions for further research, as the functional connections between the studied parameters are not fully understood.
- 25 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7585
Open AccessSerum Behavior of NT-3 and VEGFβ, Two Unstudied Growth Factors in Patients with Diabetes Mellitus and End-Stage Renal Disease
Background. DM frequently causes ESRD, a situation in which survival is impossible without chronic dialysis. This research aimed to study the tissue-regenerative capacity of ESRD patients with/without DM. For this purpose, two growth factors were studied: NT-3 and VEGFβ. To our knowledge, this is the first study on the serum behavior of NT-3 in patients with ESRD + DM and, very likely, in patients with ESRD alone. VEGFβ is also very little studied in these patient categories. Since the quasi-permanent inflammation was already clearly proven, this study focused on the anti-inflammatory capacity, taking IL-10 as a prototype, and also the interrelationships between these three factors. Method. All the aforementioned compounds were determined from serum samples, utilizing ELISA kits. Results. The results were surprising, proving a marked polarization of their serum behavior. Although the mean serum levels of NT-3 and VEGFβ were significantly increased in patients with ESRD + DM compared to those with ESRD alone, most patients in both groups had serum levels below the detection limits of the kits used. Conclusions. Although this research is in its early stages, it generates important conclusions and directions for further research, as the functional connections between the studied parameters are not fully understood.
- Open Access
- 12 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6430
Circulating miRNAs as Non-Invasive Biomarkers in Pancreatic Cancer: A Two-Phase Plasma-Based Study
Background/Objectives: MiRNAs have demonstrated promising roles in the diagnosis of pancreatic cancer and in the prognostic assessment of affected patients. Methods: We conducted a prospective pilot study including 23 patients diagnosed with advanced-stage pancreatic cancer and 10 healthy controls, matched by age and sex. In the screening phase, we evaluated the expression of 176 miRNAs in pooled plasma samples from both groups using real-time PCR. Subsequently, we validated the overexpression of selected miRNAs in individual plasma samples using the same technique. Statistical analysis was performed using IBM SPSS Statistics version 29. Results: During the screening phase, 22 miRNAs exhibited differential expression in patients with pancreatic cancer compared to healthy controls. Among these, hsa-miR-100-5p (27.8-fold increase), hsa-miR-122-5p (7.5-fold), hsa-miR-885-5p (7.2-fold), hsa-miR-34a-5p (5.7-fold), and hsa-miR-193a-5p (4.4-fold) showed the most pronounced upregulation. In the validation phase, all five candidates demonstrated significant overexpression in individual plasma samples (p < 0.001). Their circulating levels also showed associations with tumor stage (p < 0.05). Conclusions: Our findings highlight a distinct circulating miRNA signature associated with advanced pancreatic cancer, supporting the potential role of hsa-miR-100-5p, hsa-miR-122-5p, hsa-miR-885-5p, hsa-miR-34a-5p, and hsa-miR-193a-5p as minimally invasive biomarkers for disease detection and staging. Larger, multicenter studies including early-stage patients and disease control groups will be required to validate these biomarkers and determine their clinical utility.
- 12 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6430
Open AccessCirculating miRNAs as Non-Invasive Biomarkers in Pancreatic Cancer: A Two-Phase Plasma-Based Study
Background/Objectives: MiRNAs have demonstrated promising roles in the diagnosis of pancreatic cancer and in the prognostic assessment of affected patients. Methods: We conducted a prospective pilot study including 23 patients diagnosed with advanced-stage pancreatic cancer and 10 healthy controls, matched by age and sex. In the screening phase, we evaluated the expression of 176 miRNAs in pooled plasma samples from both groups using real-time PCR. Subsequently, we validated the overexpression of selected miRNAs in individual plasma samples using the same technique. Statistical analysis was performed using IBM SPSS Statistics version 29. Results: During the screening phase, 22 miRNAs exhibited differential expression in patients with pancreatic cancer compared to healthy controls. Among these, hsa-miR-100-5p (27.8-fold increase), hsa-miR-122-5p (7.5-fold), hsa-miR-885-5p (7.2-fold), hsa-miR-34a-5p (5.7-fold), and hsa-miR-193a-5p (4.4-fold) showed the most pronounced upregulation. In the validation phase, all five candidates demonstrated significant overexpression in individual plasma samples (p < 0.001). Their circulating levels also showed associations with tumor stage (p < 0.05). Conclusions: Our findings highlight a distinct circulating miRNA signature associated with advanced pancreatic cancer, supporting the potential role of hsa-miR-100-5p, hsa-miR-122-5p, hsa-miR-885-5p, hsa-miR-34a-5p, and hsa-miR-193a-5p as minimally invasive biomarkers for disease detection and staging. Larger, multicenter studies including early-stage patients and disease control groups will be required to validate these biomarkers and determine their clinical utility.
- Open Access
- 1 September 2025
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (17) , e70805
Monitoring SARS ‐ CoV ‐2 Dissemination in Wastewater and Virus Isolation in Cell Cultures: An Integrated Approach for Pathogen Detection and Surveillance
Our study presents wastewater (WW) monitoring data, focusing on determining the infectivity of SARS‐CoV‐2 in the collected samples. Additionally, a panel of different viruses has been tested in the WW samples. The untreated WW monitoring campaign took place over 1 year in Bucharest, with approximately 300 samples being collected twice a week at the wastewater treatment plant (WWTP) and an infectious diseases hospital. Our data indicated that SARS‐CoV‐2 concentrations in WW preceded the increase in the number of clinical cases by nearly 2 weeks. Differences between locations were notable, with higher raw concentrations in WW samples from the hospital than those from the WWTP. However, after normalising to population equivalent, the hospital samples concentrations dropped significantly, suggesting that WW monitoring at the urban level provides a more complete and epidemiologically relevant picture than data obtained only from hospitals. Only a few isolates could demonstrate SARS‐CoV‐2 persistence during in vitro passages. Although the success rate was low, the technique remains crucial for validating the viability of viruses. Adenovirus, Bocavirus and Reovirus were the most abundant ones in both urban and hospital wastewater. WW monitoring remains the most effective approach for tracking the dissemination of various pathogens and supporting public health authorities.
- 1 September 2025
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (17) , e70805
Open AccessMonitoring SARS ‐ CoV ‐2 Dissemination in Wastewater and Virus Isolation in Cell Cultures: An Integrated Approach for Pathogen Detection and Surveillance
Our study presents wastewater (WW) monitoring data, focusing on determining the infectivity of SARS‐CoV‐2 in the collected samples. Additionally, a panel of different viruses has been tested in the WW samples. The untreated WW monitoring campaign took place over 1 year in Bucharest, with approximately 300 samples being collected twice a week at the wastewater treatment plant (WWTP) and an infectious diseases hospital. Our data indicated that SARS‐CoV‐2 concentrations in WW preceded the increase in the number of clinical cases by nearly 2 weeks. Differences between locations were notable, with higher raw concentrations in WW samples from the hospital than those from the WWTP. However, after normalising to population equivalent, the hospital samples concentrations dropped significantly, suggesting that WW monitoring at the urban level provides a more complete and epidemiologically relevant picture than data obtained only from hospitals. Only a few isolates could demonstrate SARS‐CoV‐2 persistence during in vitro passages. Although the success rate was low, the technique remains crucial for validating the viability of viruses. Adenovirus, Bocavirus and Reovirus were the most abundant ones in both urban and hospital wastewater. WW monitoring remains the most effective approach for tracking the dissemination of various pathogens and supporting public health authorities.